BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

Contribution of the nervous system to cancer progression
Hongryeol Park1 (Research worker), Chan Hee Lee1,* (Professor)
1Department of Tissue Morphogenesis Max-Planck Institute for Molecular Biomedicine, Muenster (D-48149), Germany,
2Department of Biomedical Science and 3Program of Material Science for Medicine and Pharmaceutics, Hallym University, Chuncheon (24252), South Korea
Cancer progression is driven by genetic mutations, environmental factors, and intricate interactions within the Tumor Microenvironment (TME), encompassing a complex network involving neurotrophic factors. The interplay between cancer cells and peripheral nerves, particularly the impact of neurotrophic factors such as NGF, BDNF, and GDNF, are associated with poor prognosis across various cancer types. Moreover, sympathetic and parasympathetic autonomic regulation plays a significant role in influencing tumor growth. Sympathetic signaling predominantly promotes tumor progression, whereas the role of parasympathetic signaling varies among different cancer types. These effects can occur by directly affecting tumor cells or regulating immune cell functions within the TME. In addition, the sensory nerves significantly promote cancer progression. We also describe the contribution of the CNS to Cancer-Associated Cachexia (CAC), characterized by tissue wasting and a reduced quality of life. This process involves pathways via GDF15-GFRAL signaling and hypothalamic POMC neurons. Our review underscores the multifaceted interactions between the nervous system and cancer progression and presents promising avenues for targeted therapeutic strategies.
Abstract, Accepted Manuscript(in press) [Submitted on January 24, 2024, Accepted on March 19, 2024]
  © KSBMB. All rights reserved. / Powered by INFOrang Co., Ltd